Discovery Labs

Discovery Laboratories: Disappointment With Delay In Surfaxin Launch Creates An Opportunity
Seeking Alpha
Wed, 12/19/12 - 11:21 am
Discovery Labs
Surfaxin
Discovery (DSCO) Says SURFAXIN May Save Hospitals ~$390K Per 100 Infants Treated
StreetInsider.com
Wed, 12/5/12 - 10:32 am
Discovery Labs
Surfaxin
bronchopulmonary dysplasia
A $3 Biotech Play With Recent Positive Catalysts
Seeking Alpha
Sun, 08/26/12 - 10:57 am
Discovery Labs
This Just In: More Upgrades and Downgrades
Motley Fool
Sat, 08/25/12 - 11:38 am
Discovery Labs
Oncothyreon
Threshold Pharmaceuticals
Puma Biotechnology
Immunogen
Pharmacyclics
Infinity Pharmaceuticals
Discovery Labs rises as analyst forecasts $121 million in respiratory product sales by 2018
Yahoo/AP
Fri, 08/24/12 - 11:17 am
Discovery Labs
respiratory distress syndrome
Afectair
Surfaxin
Discovery Labs Reports Second Quarter 2012 Financial Results
Thu, 08/2/12 - 12:31 pm
Discovery Labs
earings
For Biotech Takeovers, Timing is Key
TheStreet.com
Wed, 04/4/12 - 08:44 am
M&A
biotech
Vivus
Arena Pharmaceuticals
Discovery Labs
Discovery Laboratories posts smaller 4th-qtr loss on lower expenses, stock-related gain
Yahoo/AP
Thu, 03/29/12 - 12:13 pm
earnings
Discovery Labs
Opportunity On The Horizon For Discovery Laboratories Investors
Seeking Alpha
Mon, 03/26/12 - 12:17 pm
Discovery Labs
Discovery Labs Wins Approval for Drug to Ease Baby Breathing
Bloomberg
Wed, 03/7/12 - 10:13 am
FDA
Discovery Labs
Surfaxin
4 Small-Cap, High-Risk, High-Reward Bio-Pharmas
Seeking Alpha
Fri, 03/2/12 - 10:40 am
Astex
BioSante
Discovery Labs
Galena Biopharma
OncoVista Innovative Therapies
Spectrum Pharmaceuticals
Biotech Stock Mailbag: Cyclacel Fallout, the Skinny on Vivus, Celldex's Crash
TheStreet.com
Fri, 03/2/12 - 10:10 am
Cyclacel
Vivus
Celldex
Astex
Discovery Labs
Exelixis
[video] The Next Big Thing in Biotech: Discovery Labs
TheStreet.com
Fri, 03/2/12 - 10:07 am
Discovery Labs
Merck, Pfizer, Bristol-Myers, Affymax, Chelsea Therapeutics Face Key Dates in March
Minyanville
Wed, 02/29/12 - 04:52 pm
Merck
Pfizer
Bristol-Myers Squibb
Chelsea Therapeutics
Affymax
Astex
JNJ
Discovery Labs
Ariad Pharmaceuticals
NeurogesX
Amgen
9 Biotech Companies With FDA Approval Decision Dates In Q1 2012
Seeking Alpha
Mon, 12/12/11 - 11:14 am
FDA
Fentanyl SL
INSYS Therapeutics
Dapagliflozin
Bristol-Myers Squibb
Prochieve
Columbia Laboratories
Discovery Labs
Surfaxin
NeurogesX
Qutenza
Curis
Roche
vismodegib
Chelsea Therapeutics
Northera
ONYX Pharmaceuticals
Carfilzomib
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Amarin
AMR101
Ironwood
linaclotide
Merck
Ariad
ridaforolimus
Vivus
Qnexa
Avanafil
Amgen
Xgeva
Cell Therapeutics
pixantrone
Kalydeco
Vertex
ONYX Pharmaceuticals
Carfilzomib
Pfizer
Bristol-Myers Squibb
Eliquis
Chelsea Therapeutics
Northera
Levadex
MAP Pharmaceuticals
Roche
Curis
vismodegib
Biogen Idec
Elan
Tysabri
Amylin
Bydureon
Dapagliflozin
Uplypso
Protalix BioTherapeutics
Teva Pharmaceuticals
BioSante
Bio-T-Gel
Corlux
Corcept Therapeutics
Discovery Labs
Surfaxin
Biotech Stock Mailbag: Bio-Hazards
The Street
Sat, 03/26/11 - 10:00 am
Telik
Xoma
Genta
Cell Therapeutics
Discovery Labs
Cel-Sci
Biotech Stock Mailbag: Orexigen Therapeutics
TheStreet.com
Fri, 01/28/11 - 12:13 pm
Orexigen
Contrave
Arena Pharmaceuticals
Vivus
Avanir
Discovery Labs
Cel-Sci
PharmaBio increases stake in Discovery Laboratories
Bizjournals.com
Wed, 10/13/10 - 12:02 pm
Discovery Labs
PharmaBio
Life Sciences Companies Capture the Cash
Seeking Alpha
Sun, 06/20/10 - 11:21 am
Abbott Laboratories
Aeterna Zentaris
Bayer
Celsion
Cytori
Genzyme
Discovery Labs
GTC Biotherapeutics
Gen-Probe
Neurocrine
Pharmacyclics
Teva Pharmaceuticals
ProUroCare
SafeStitch Medical

Pages